Endoluminal Negative Pressure Wound Therapy (E-NPWT) for anastomotic leakage after rectal resection by Runkel, Norbert Severin Friedrich & Birk, Mechthilde
NEGATIVE PRESSURE WOUND THERAPY JOURNAL, VOL. 1, NO. 1, DECEMBER 2014 1
Endoluminal Negative Pressure Wound Therapy
(E-NPWT) for anastomotic leakage after rectal
resection
Norbert Runkel, MD, Ph.D., Mechthilde Birk
REVIEW
Abstract—Background: Local management of anastomotic
leakage after rectal cancer resection has traditionally consisted
of rinsing and drainage. Transanal endoluminal application of
NPWT (E-NPWT or endo-VAC or endo-sponge) is an interesting
novel concept that has been explored in a few studies and case
series over the last decade. We report herein our institutional
experience over a three year period during which E-NPWT
was the local treatment of choice for all cases with anastomotic
leakage after rectal resection.
Patients and Methods: This study retrospectively evaluated the
clinical charts of 147 consecutive patients who underwent ante-
rior rectal resection from 2011-2013. A postoperative anastomotic
leak occurred in eight (5%) patients from two straight anasto-
moses, one side-to-end construction, and five colonic pouches.
All patients had undergone curative anterior resection with
diverting ostomy. Transanal debridement and application of a
trimmed foam were performed by rigid or fexibel endoscopy
and started without delay after confirmation of diagnosis in seven
patients 8-15 days postoperatively. In one patient E-NPWT began
after failed fibrin-glue treatment 6 weeks later. The foams were
connected to a standard vacuum pump with the pressure set at
-70mmHg in a continuous mode. E-NPWT was maintained for
a median period of 10 (5-25) days. The treatment intervals were
typically 2-3 days.
Results: Complete healing was achieved in three cases during
E-NPWT. In the remaining five patients, the defect reduced in
size to allow further spontaneous healing. This occurred twice.
One persistent sinus was successfully sealed with fibrin glue.
One persisting recto-vaginal fistula required surgical closure.
One large defect secondary to ischemic pouch necrosis required
secondary pouch explantation and permanent colostomy. The
overall ileostomy reversal rate was 75%.
Conclusion: E-NPWT is feasible and without severe side
effects. Early initiation prevents septic progression and results
in a high closure rate in patients with pelvic leakage. Although
complete healing is not achieved in recto-vaginal fistulas or is-
chemic necrosis of the neorectum, E-NPWT may play a potential
role in bridging and damage control.
Keywords—NPWT, Endo-VAC, Endo-Sponge, anastomotic
leakage, rectal cancer, postoperative complication
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ANASTOMOTIC Anastomotic dehiscence is associatedwith an increased early and late morbidity and mortality
causing re-interventions, prolonged hospitalization, impair-
ment of anorectal function, and a delay of adjuvant chemother-
apy and stoma reversal. The non-operative management of
leakages has recently undergone a fundamental change through
the endoscopic adoption of modern concepts of negative
pressure wound therapy (NPWT). The novel transanal endo-
luminal application of NPWT (E-NPWT) has been published
in case reports1, 2 and small series from central Europe.3–11
The potentials and limitations of E-NPWT remain largely
unknown to the colorectal community despite the availability
of a commercial kit (Endo-SPONGEr, B. Braun Melsungen,
Germany). The aim of this study was to analyze our results
of E-NPWT in a non-selected consecutive group of patients
over a 3-year period. We had been using E-NPWT routinely
for managing all leaks in the pelvic cavity for some time.
II. PATIENTS AND METHODS
A. Patients
This study analyzed a three-year period since 2011 when
E-NPWT had become the first-line treatment for patients with
symptomatic leaks after rectal resection with an extraperitoneal
anastomosis. A total of 161 patients with rectal cancer under-
went abdomino-perineal (n = 14) or anterior rectal resection
with either partial (PME; n = 30) or total mesorectal resection
(TME; n = 107) between 1/2011 and 12/2013.
The rate of laparoscopic surgery was 95% without any
conversion. Sixteen patients with PME received a double sta-
pled end-to-end colo-rectostomy (straight anastomosis), and 14
patients with PME had no anastomosis (Hartmann’s situation).
The neorectum after TME were constructed as a colon-pouch
in 96 patients, a side-to-end reconstruction in 11 patients,
and a straight anastomosis in one patient. The anastomoses
after TME were double stapled or hand sewn anastomoses
in 70 and seven patients, respectively. The anastomoses were
protected by enterostomies in 39% of patients with PME
and in 99% of patients with TME. The anastomoses were
not routinely controlled in the early postoperative period in
an asymptomatic patient. In case of clinical suspicion of an
anastomotic leak, however, CT-scan with transanal contrast
medium and endoscopy were performed without delay. The
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integrity of the anastomosis was always confirmed prior to
stoma reversal at a later stage.
B. Technique
The technique is similar to that described in detail by
Glitsch et al. (5). In summary, endoscopy is performed using
flexible scopes or, preferentially rigid instruments. The cavity
is entered through the anastomotic defect, which is widened
when necessary. Clearing the infectious cavity from debris and
generous rinsing with saline are mandatory procedures each
time of re-intervention. A polyurethane foam-based NPWT
system (RENASYS GOTM, Smith and Nephew Healthcare,
Hull, United Kingdom) is used. The pressure level is set at
−70mmHg. The foam is trimmed according to the size and
shape of the cavity, so that it can fill out the entire lumen of
the wound. The following foams are consequently reduced
in size to foster the collapse of the cavity. The sponge is
placed inside the cavity or, when downsizing occurs, partially
or totally within the rectal lumen. This is why fecal deviation
is considered mandatory in our institution.
III. RESULTS
Postoperative anastomotic leakage was detected in eight pa-
tients (Table I). Anastomotic leakage was clinically identified
in six five male and two female patients (total leakage rate
5,0%), seven of whom had undergone TME (TME leakage
rate 6,5%) and one PME (PME leakage rate 3,3%). Leakage
occurred in five colon-pouches, one side-to-end construction,
and two straight anastomoses. All but two hand-sewn intraanal
anastomoses had been double-stapled. All neorectums has
been protected by an ileostomy. Neoadjuvant therapy had been
given to five of eight patients prior to resection.
Leakage was associated with severe sepsis in two cases
(patient No. 1, 2) one of whom (patient No. 1, TME and
colon-pouch) rapidly developed sepsis with multiorgan failure
(MODS) caused by peritonitis ascending from a pinhead sized
leak between the linear stapler line at the end of colonic stump.
This patient required emergent re-laparoscopy and lavage in
addition to E-NPWT. The anastomotic defect closed within
10 days, however, recovery from MODS was much prolonged.
The ileostomy was never taken down because of anal sphincter
insufficiency and systemic tumor disease.
Three were four small leaks (<1 cm), one midsize leak (<2
cm) and three major leaks (>1/3 circumference), one of which
was secondary to partial ischemic necrosis of the neorectum
(patient No. 6, TME with straight anatomosis).
Diagnosis of insufficiency was established after a median of
8.5 days (range 2-18). Endoscopic management with E-NPWT
was initiated without delay in seven patients and after 6 weeks
in one patient (No. 4) in whom fibrin-sealing had been tried
without success. E-NPWT was maintained for a median period
of 10 (5-25) days. The endo-sponge was typically exchanged
in 2-3 day intervals. The intervention was performed under
general anesthesia in the case of sepsis (No. 1), who had
abdominal revision simultaneously, and under surgeon-guided
Propofol-sedation in four patients, and without any in three.
The leakage/cavity completely healed during E-NPWT in
three cases. In the remaining five patients, the defect became
clean and small enough to allow further spontaneous healing.
This occurred twice. One persistent sinus was successfully
sealed with fibrin glue (patient No. 4). The ileostomy was
subsequently taken down in five patients. The ileostomy
remained in place in one patient due to sphincter insuffi-
ciency and progressive tumor disease. In one female patient
(No. 7), a recto-vaginal fistula persisted despite reduction in
size. She underwent re-laparoscopy, omental interposition and
transanal/transvaginal suture. Her ostomy was finally taken
down 3 months later. Following restauration of continuity,
overall bowel function and defecation were not apparently
different from the normal range after anterior rectal resection.
The patient with pouch-necrosis (patient No. 6) re-
quired subsequent operative pouch removal with permanent
colostomy, because his defect remained significant despite 25
days of E-NPWT.
IV. DISCUSSION
Anastomotic leakage remains the most devastating compli-
cation after low rectal resection. Numerous published studies
have analyzed risk factors and protective measures such as
diverting ileostomy, however there is little science regarding
clinical management of leakage. Most of the knowledge and
measures that are being passed down from surgical leaders
to their trainees are experience- rather than evidence-based.
This includes operative revisions for patients with sepsis and
conservative treatment by rinsing and drainage of the leakage
cavity in patients without peritonitis. Internally applied NPWT
is a new non-operative treatment modality first described
by Weidenhagen et al. from Munich in 2003 for active
rather than passive drainage.3 The authors have named the
technique endoscopic vacuum-assisted closure of anastomotic
leakage but another group from Germany has proposed the
term endoscopic transanal vacuum-assisted rectal drainage
(ETVARD).5, 9
We believe that both terms do not precisely describe the
potential role of negative pressure therapy. It pursues four
principle goals: firstly, effective suction drainage inside the
septic cavity with negative pressure transported to the foam-
tissue contact zone; secondly interruption of continuous con-
tamination of the cavity by colonic mucous and stool; thirdly
reduction of the size of the cavity, and lastly healing by
promoting granulation. We therefore prefer the term endolumi-
nal negative-pressure wound therapy (E-NPWT). NPWT is a
generic name and is not associated with a particular company
such as Endo-VAC (V.A.C. TM KCI, San Antonio, TX, USA)
or Endo-SPONGETM (B. Braun Melsungen, Germany).
The basic feature of this method is the placement of an
open-cell foam into the abscess cavity of the anastomotic
leakage and/or into the rectal lumen. The suction tube fixed to
the sponge is placed transanally and connected to a vacuum
pump. The commercially available kit (Endo-SPONGETM, B.
Braun, Melsungen, Germany) facilitates the introduction of
the sponge with the help of a pusher and overtube. But many
surgeons use self-made devices on the basis of off-label use
of clinically established foam-based systems just as we did.
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This minimally invasive method is applicable by rigid
or flexible endoscopy. If required propofol anesthesia is a
comfortable adjunct to achieve painless debridements and
exchanges of the sponges. It is our impression that pain
reduces with progressive control of pelvic sepsis.
Most technical details of E-NPWT have been adopted from
standard negative pressure therapy for acute wounds and open
abdomen. The method resembles evidence-based recommen-
dations for acute wound s and open abdomen developed by an
international expert panel chaired by the treatment.principle
author of this study (N.R.).12–14 Repetitive endoscopic de-
bridements remain the cornerstones with intervals of revision
chosen as required. NPWT is not a substitute for thorough
or repeated surgical debridement. Latter should be performed
prior to placement of the NPWT dressing. Application of
NPWT to cavities containing necrotic tissue is contraindicated.
Intervals of re-intervention should not be longer than 3-5
days to prevent granulation ingrowth into the sponge cells.
Foam rather than gauze has been the woundfiller of choice in
our study and all other publications. Similarly, the use of a
protective interface has not been reported. It is important to
emphasize than E-NPWT should be continued until healing
is complete or until stagnation is observed. An alternative
treatment protocol must be considered in the absence of
further progress of healing. If the remaining sinus is minute,
spontaneous closure will occur without further intervention in
the presence of an enterostomy.
A wide range of negative pressures have been reported
up to 125 mmHg,4 however no studies have investigated
the most appropriate level of negative pressure. Surprisingly,
even higher levels were applied with the use of high-vacuum
wound drainage systems (B Braun, Melsungen Germany,
Redovac R© 400 ml).7 In contrast, we recommend pressure
levels of less than −80mmHg and as low as −50mmHg
in vulnerable patients (e.g. those with sepsis). The prevalent
untested assumption is that the higher the pressure levels, the
higher the potential for damage to the surrounding structures.
This is in accordance with recommendation for temporary
closure of open abdomen with NPWT.14 There has not been a
single incidence of any damage secondary to E-NPWT in the
literature. In our and in all other cited papers the pressure was
applied in a continuous mode. Intermittent pressure (where
pressure settings fluctuate between on and off) or variable
pressure levels (where pressure setting fluctuate between high
and low) have not been explored for endoluminal therapy.
We strictly used E-NPWT within the hospital setting as a
consequence of reimbursement policies in Germany, however,
selected patients can be managed on an outpatient basis as
was demonstrated in the Netherlands.11
Few series have been published over the last ten years
since the first abstract communication by Weidenhagen et al.
3 from Munich, Germany in 2003. Nagell and Holte4 from
Copenhagen, Denmark reported a small group of four patients
with anastomotic leakage after rectal resection with protective
ileostomy. E-NPWT treatment was immediately commenced
at the time of diagnosis of insufficiency. One patient was lost
following cerebral hemorrhage. The three remaining patients
were treated with transrectal vacuum for a median of 13–37
days and completely healed within 43, 51, and 19 days. The
control group of six patients healed after 336days (52–1,464).
The Munich group6 described a series of 29 patients treated
with endo-sponge. Most patients underwent surgery for cancer
including nine of them with neoadjuvant radiochemotherapy.
Definitive closure was achieved in all but one patient (97%).
Treatment lasted 34 days on average (range 4–79 days) and
the mean number of sponge exchanges was 11 (range 1–27).
Stoma reversal rate was 22 out of the 25 patients with a
protecting stoma.
Mees et al. 7 from Muenster, Germany, examined a
small series of 10 patients with a presacral abscess following
anastomotic leakage after low anterior resection or restorative
proctocolectomy. E-NPWT was compared with traditional
management (five patients in each group). Negative pressure
was applied for a median time of 27 days without specific
complications. Wound healing was significantly faster with
E-NPWT compared to traditional management. Hospital stay
was slightly shortened by E-NPWT. Median time for wound
closure was 45days (range 32–68 days) compared to 101 days
(range 79–125 days) in the control group (p<0.001).
Riss et al. 8 from Vienna, Austria, used E-NPWT for
anastomotic disruption (6 patients) and rectal stump disruption
(3 patients). Median time of sponge treatment was 3 weeks
(2-8 weeks). Healing was induced in 6 (66%) patients. Treat-
ment failure occurred in patients with near total anastomotic
disruption. Pain during E-NPWT was low (median 3, range
0-6 according to the visual analogue scale VAS of 0-10.
The long-term efficacy of initially successful endo-sponge
assisted therapy was assessed in another paper from the same
group.10 Twenty patients were recruited from six surgical
departments in Vienna. The median follow-up duration was 17
months (1.5-29.8). Five patients (25%) developed a recurrent
abscess. Median time between last day of endo-sponge therapy
and occurrence of recurrent abscess was 255 days (21-733).
One of these patients was treated by computed tomography-
guided drainage, and in 3 patients Hartmann’s procedure
had to be performed. One patient had only minimal clinical
signs and further therapy was still under discussion at the
time of publication. The authors speculated that late onset of
anastomotic leakage was associated with a tendency for a high
probability of recurrent abscess formation
Glitsch et al. 5 from Greifswald, Germany, treated a total
of 17 patients with anastomotic leakage after resection of
the rectum or rectosigmoid colon with instant endoscopic
debridement and endoscopic placement of foam into the cavity.
The mean duration of therapy was 21 days, with a mean
of 5 sponge exchanges and 11 endoscopies. Treatment was
successful in 16 patients. The mean total time to closure of
the cavity was 53 days. One patient required a Hartmann’s
procedure.
A second paper from the same group prospectively inves-
tigated the impact of neoadjuvant radiochemotherapy on en-
doscopic transanal vacuum-assisted rectal drainage.9 E-NPWT
was performed as first-line treatment in 26 rectal cancer pa-
tients including 14 following neoadjuvant radiochemotherapy.
In 23 of 26 patients, E-NPWT was successfully completed. Ra-
diochemotherapy was significantly associated with larger size
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of leakage cavity, longer treatment duration, higher frequency
of endoscopies and sponge exchanges, and prolonged closure
time.
A Dutch multicenter observational E-NPWT study included
16 patients with leakage after surgery for rectal cancer (n =
13) or ulcerative colitis (n = 3).11 The total closure rate was
56%). Of the 16 patients, eight patients started with the endo-
sponge treatment within 6 weeks (13–39 days) after the initial
surgery. In the remaining eight patients treatment was started
later than 6 weeks (43–1,602 days) after surgery. The closure
rate was 75% in the early treatment group vs. 38% in the
late treatment group (p = 0.315). Closure was achieved in a
median of 40 (range 28–90) days with a median number of
13 sponge replacements (range 8–17).
In our present study on a 3-year series of non-selected
consecutive patients with leakage after anterior resection for
rectal cancer, the closure rate without further surgery was
75% (6/8 patients). The closure rate increased to 88% (7/8
patients) when the patient with additional surgical closure of
a recto-vaginal fistula was included. All patients had a primary
diverting ostomy which we consider mandatory for E-NPWT.
The principle of fecal deviation contributed to our low overall
leakage rate of 5% after rectal resections.
Until now, there is insufficient literature to determine
whether E-NPWT is superior to wait-and-see policy under fe-
cal diversion. But a few messages from the available evidence
can be extracted. Firstly, E-NPWT is technically feasible with-
out complications associated with this treatment. Secondly,
some principles of care from NPWT for external wounds can
be adopted for internal wounds: the priority of debridement,
active suction at the contact zone of sponge and tissue, the
harmlessness of negative pressure less than −100mmHg, the
time intervals and the search for other modalities when further
progress is lacking, a high level of expertise and hospital
resources required. The effects of E-NPWT resemble those
of NPWT for external septic wounds, too: rapid re-direction
of septic material, sealing in the early phase and promotion of
granulation tissue with reduction of the cavity size in the later
phase. Closure of the leakage whole/fistula opening can be
expected in the great majority of patients within 3-6 weeks. E-
NPWT is well tolerated by the patients with minimal analgesic
requirements between the intervals of sponge insertion and
maximal mobility.
The third massage from the available evidence regards
limitations of E-NPWT. One negative prognostic factor is
preoperative radiochemotherapy.9 The timing of the initiation
of the treatment plays an important role. Early onset within 6
weeks of surgery resulted in a closure rate of 75% compared to
a 38% closure rate in patients that started later (p = 0.315).11
The overall closure rate of the Dutch trial (56%)11 was lower
than that achieved in Munich (97%)6 or in our institution
(75%). The Dutch explanation seems plausible that the pro-
gressive development of fibrosis of and around the neorectum
precludes alignment of the bowel with the abscess cavity. We
therefore recommend to initiate E-NPWT without delay once
the diagnosis of leakage is confirmed. This emphasizes the
need for instant access to flexible and or rigid endoscopy.
Another important limitation of E-NPWT is the complexity
and size of the anastomotic defects. Leakages secondary to
circumscribed stable line disruption are good candidates for
complete healing. Subtotal dehiscence or multiple fistulas8 or
large cavities5 may not be closed by this technique. We have
identified necrosis as another cause of failure. When leakage
is a result from ischemic wall necrosis of the neorectum as ob-
served, closure cannot be achieved. Under these circumstances
the value of E-NPWT is limited to damage control and to
bridge for later definitive surgical excision of the neorectum.
A re-construction of a neorectum was not considered in our
patient.
Finally, many questions regarding selection of patients and
technical details of application remain to be answered such as
the comparison of commercial versus self-made kits. Future
studies should examine the long term outcome and function
after successful treatment with E-NPWT and the necessity of
diverting the fecal stream. Studies should explore the potentials
of E-NPWT in intraperitoneal leaks after colon resection and
for prophylactic perioperative use.
V. CONCLUSION
Our study adds another piece of evidence to the literature
regarding the management of anastomotic leakages after rectal
resection. E-NPWT is feasible and without severe side effects.
Onset should be early or immediate after diagnosis. Closure
of the cavity and distracted anastomosis can be achieved in
high numbers within several weeks facilitating the take down
of the protective ostomy at a later stage. E-NPWT may help
reversing sepsis in pouch necrosis but fails to induce complete
healing in this situation.
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